Earnings History Data for Lisata Therapeutics, Inc. (LSTA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Lisata Therapeutics, Inc.
Lisata Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in discovery, development and commercialization of therapies for the treatment of advanced solid tumors and other major diseases. The company's principal product candidate includes LSTA1. Lisata Therapeutics Inc., formerly known as Caladrius Biosciences Inc., is based in BASKING RIDGE, N.J.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-02-2024 | AH | LSTA | Lisata Therapeutics, Inc. | 24.58 | -0.66 | -0.86 | -0.76 | Lisata Therapeutics GAAP EPS of -$2.58 beats by $0.33 [2/29/2024 4:42 PM] |
3.14 | 0.21 (7.12%) |
3.04 | 0.11 (3.75%) |
1.95 - 4.53 | 9,256 | 10,000 | 0 | ||
| 02-11-2023 | AH | LSTA | Lisata Therapeutics, Inc. | 17.67 | -0.65 | -0.93 | -1.48 | Lisata Therapeutics GAAP EPS of -$0.65 beats by $0.28 [11/2/2023 4:45 PM] |
2.40 | 0.22 (10.09%) |
0.0 | 0.0 (0.00%) |
1.95 - 4.53 | 46,584 | 10,000 | 0 | ||
| 14-08-2023 | AH | LSTA | Lisata Therapeutics, Inc. | 21.93 | -0.50 | -0.70 | -1.65 | Lisata Therapeutics GAAP EPS of -$0.50 beats by $0.20 [8/14/2023 5:08 PM] |
2.69 | -0.01 (-0.37%) |
0.0 | 0.0 (0.00%) |
2.36 - 9.75 | 11,791 | 90,000 | 0 | ||
| 09-05-2023 | AH | 4:05 PM ET (May 9) |
LSTA | Lisata Therapeutics, Inc. | 25.79 | -0.77 | -0.81 | -1.05 | Lisata Therapeutics GAAP EPS of -$0.77 beats by $0.04 [5/9/2023 4:30 PM] |
3.27 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
2.36 - 9.75 | 6,512 | 10,000 | 0 | |
| 30-03-2023 | AH | 4:05 PM ET (Mar 30) |
LSTA | Lisata Therapeutics, Inc. | 26.17 | -0.76 | -0.96 | -1.65 | Lisata Therapeutics GAAP EPS of -$0.76 beats by $0.26 [3/30/2023 4:23 PM] |
3.25 | 0.06 (2.04%) |
0.0 | 0.0 (0.00%) |
2.36 - 11.70 | 20,926 | 10,000 | 0 | |
| 10-11-2022 | AH | After the close (Nov 10) |
LSTA | Lisata Therapeutics, Inc. | 29.33 | -1.48 | -1.27 | -1.80 | Lisata Therapeutics GAAP EPS of -$7.88 misses by $6.61 [11/10/2022 4:19 PM] |
3.69 | -0.01 (-0.27%) |
3.60 | -0.10 (-2.70%) |
3.50 - 17.10 | 15,109 | 10,000 | 101 | |